Press Releases for BLUD

Press Releases
Shalov Stone Bonner & Rocco LLP Announces Class Action Against Immucor, Inc.
Immucor Announces 2 Million Share Increase to Stock Repurchase Program
Immucor Submits 30-Day Response to FDA; Organizational Realignment Supports Quality Initiatives
Immucor Announces Fiscal Fourth Quarter Results
Immucor Appoints Chief Operating Officer
Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
Immucor Responds To FDA Notice
Immucor Announces Fiscal Year 2010 Guidance
Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement
Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
Immucor Receives Subpoena From Department of Justice
Immucor Announces Fiscal Third Quarter Results - Apr 6 2009 10:51PM
Immucor Announces Fiscal Third Quarter Results - Apr 6 2009 4:26PM
Immucor to Announce Fiscal Third Quarter Financial Results on Monday, April 6, 2009
Immucor Announces New Vice President, Operations
Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
CORRECTING and REPLACING Zacks Earnings Preview: Bed Bath & Beyond, Global Payments, KB Home and Immucor
Immucor Schedules Second Quarter Earnings Release and Conference Call
Semi-Annual Changes to the NASDAQ Q-50 Index - Dec 12 2008 8:41PM
Immucor Announces Record Fiscal First Quarter Results
Immucor Schedules First Quarter Earnings Release and Conference Call
Immucor Closes BioArray Acquisition
Immucor, Inc. Adds Board Members
Immucor Announces Record Year End and Fiscal Fourth Quarter Results
Immucor Schedules Fourth Quarter Earnings Release and Conference Call
FDA Accepts Immucor's Response to Warning Letter
Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance
Immucor Schedules Fiscal 2009 Guidance Call
Immucor Responding to FDA Warning Letter - Jun 1 2008 11:01AM
Immucor CEO's Italian Trial Moves Toward Second Phase
BellwetherReport.com Free Analyst Review for PNM, TPX, VIP and BLUD
Bellwether Report Is Closely Watching SEBL, XOMA, BLUD, and SCHN